Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study
2014 ◽
Vol 45
(2)
◽
pp. 509-515
◽
2017 ◽
Vol 81
(2)
◽
pp. 333-337
◽
2014 ◽
Vol 46
(6)
◽
pp. e113-e119
◽
2019 ◽
Vol 37
(6)
◽
pp. 1266-1273
◽
Keyword(s):